Experiment 69172

Details

PropertyValue
Pharmacology
Administration routeROUTE NOT GIVEN
OrganismEmpty organism
CitationSCHWAHN,BC: HAFNER,D: HOHFELD,T: BALKENHOL,N: LARYEA,MD: WENDEL,U:. (2003). PHARMACOKINETICS OF ORAL BETAINE IN HEALTHY SUBJECTS AND PATIENTS WITH HOMOCYSTINURIA.. 55(1)
Amount utilized
Compound isolated
DiseaseBETAINE PLASMA CONCNS. CHANGE RAPIDLY AFTER INGESTION. ELIMINATION HALF-LIFE INCREASED DURING CONTINUOUS DOSING OVER 5 DAYS. BETAINE IS MAINLY ELIMINATED BY METAB.
Dose amount50.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitKG
Dose expressionDOSE
GenderMALE